Faith Santos -Caratao, MD -Diabetes, Thyroid and Endocrine Diseases

29/01/2026

Good day . Im helping a friend who no longer needs these supplies to sell them at a lower price .
Kindly send me a pm if interested .

nutren diabpro (sealed)
expiry
2 cans 2026 nov
6cans 2027 april

1800 each can, take all and get bulk discount

Thank you.

15/01/2026

Processed meats like deli ham have been officially classified as Group 1 carcinogens by the World Health Organization, placing them in the same category as substances known to cause cancer. This designation reflects strong evidence linking regular consumption of these meats to an increased risk of colorectal and stomach cancers.

Biologically, deli ham contains compounds such as nitrates, nitrites, and preservatives that, when metabolized in the body, can form carcinogenic compounds. Cooking and processing methods may also contribute to the formation of harmful chemicals that damage DNA and promote abnormal cell growth. Regular consumption increases cumulative exposure, raising the likelihood of cancer development over time.

Psychologically, awareness of these risks empowers individuals to make informed dietary decisions. Reducing intake of processed meats and focusing on nutrient-dense, whole foods—like fruits, vegetables, legumes, and unprocessed proteins, supports overall health and reduces exposure to potential carcinogens. Small, consistent dietary changes can have meaningful long-term effects on well-being.

Socially, this classification highlights the importance of public health guidance and education about food choices. It encourages balanced diets, moderation, and consideration of alternatives for meals that traditionally rely on processed meats.

While occasional consumption is unlikely to cause immediate harm, understanding the associated risk allows people to plan meals that support long-term health. Choosing fresh, minimally processed foods strengthens the body, lowers cancer risk, and promotes overall wellness.

Be mindful of processed meats, prioritize whole foods, and make choices that protect your health over a lifetime.

11/01/2026

Good day dear patients.
Kindly see the changes in our schedule for the weeks ahead.

Thank you!

25/12/2025

Dearest patients ,
Praying that you all have a wonderful and meaningful christmas celebration with your family.

God chose to walk among us so we may not only see but feel His presence.

Merry CHRISTmas 🥰

02/12/2025

Metformin, a widely prescribed drug for type 2 diabetes, has been trusted for over 60 years to regulate blood sugar levels. But scientists are now uncovering something unexpected—metformin appears to influence the brain as well.

New studies suggest that this humble medication may support cognitive health by reducing inflammation and improving memory-related processes in the brain. Research published in journals like Aging Cell and Nature Communications found that metformin may activate AMPK, a cellular energy sensor that not only helps manage insulin but also supports brain plasticity and repair.

Animal studies have shown that metformin may enhance the growth of new neurons in the hippocampus, the area involved in memory. In some human observational studies, long-term metformin users showed lower rates of cognitive decline and Alzheimer's disease risk—although more research is still needed to confirm these effects in clinical trials.

Some researchers are even exploring metformin’s potential as an anti-aging therapy because of its broader impact on inflammation, cellular repair, and mitochondrial function. That said, it’s not a brain drug and shouldn’t be taken for that purpose unless prescribed.

The discovery that a decades-old diabetes medication could influence brain function highlights how much we’re still learning about the interconnectedness of the body. It also opens the door to repurposing existing drugs for new therapies.

What was once only known as a blood sugar stabilizer may now be part of a bigger conversation around brain health and longevity.

26/11/2025

Portion control tips😊

Simple portions pero big impact on your health.

Follow PCEDM for more health-related content.

24/11/2025

Clinic is cancelled today
Nov 25,2025.
Stay safe everyone.

02/11/2025

Good day dear patients
For everyone’s safety , clinic schedule on Nov 4,2025 ( Tuesday) is cancelled.
Kindly contact ika to reschedule your appointment.
Let’s all pray for each others safety.

01/11/2025

Dear Patients
We are having some technical issues with our page’s messenger.
For urgent concerns please contact ika.
Will update you once we have fixed the issue.
Thank you

08/10/2025

On World MCT8 Deficiency Day, we want to increase awareness of MCT8 Deficiency, a very rare genetic condition caused by a genetic mutation in the SLC16A2 gene. Thyroid hormones are particularly important for proper brain development during pregnancy and early childhood.

📌 In this disorder, also called Allan-Herndon-Dudley Syndrome (AHDS), thyroid hormone is unable to enter cells in the brain because of a defect in a thyroid hormone transporter called MCT8.

📌At the same time, excess thyroid hormone, specifically T3 (triiodothyronine), enters tissues in the rest of the body, which typically leads to complications. As a result, patients are born with severe developmental delay from hypothyroidism (not enough thyroid hormone) in the brain, while at the same time they experience hyperthyroidism (too much thyroid hormone) in the rest of their body.

📌Patients are largely dependent on parents/caregivers during all stages of life.

📌Diagnosis:

Males with developmental delay, decreased muscle tone, increased resting heart rate, and poor weight gain should have a blood test to measure the level of thyroid hormones.

A blood test is performed to confirm the diagnosis by detecting a genetic mutation in the SLC16A2 gene.

📌The main difficulty in the diagnostic trajectory includes:

🔹late diagnosis
🔹visiting multiple doctors

📌Efforts to detect patients with MCT8 deficiency during neonatal screening may be an important step in reducing the diagnostic delay.

📌There is ongoing research for therapies using different forms of thyroid hormone that do not require the MCT8 to enter the cells of the brain.

📌This year, the European Commission granted marketing authorization for a medication for the treatment of peripheral thyrotoxicosis in patients with monocarboxylate transporter 8 (MCT8) deficiency (Allan-Herndon-Dudley Syndrome), from birth.

This marks a significant milestone for the MCT8 community, providing the first authorized treatment option in the EU for this rare condition.

📌More research, progress in therapy research, and collaboration with healthcare professionals, patient advocates, and regulatory bodies are needed.

08/10/2025

For patients looking for a reputable psychiatrist , I highly recommend Dr. Euriz Calmerin. She caters to pedia, adult and geriatric patients.
Lets not take our mental health for granted😊

28/08/2025